|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 16/09/14 | CHUGAI PHARMACEUTICAL : Roche's $8 billion InterMune buy not a signal for more big deals | RE |
| 04/09/14 | Roche : rules out mega deals, open to smaller ones - paper | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Chief Tech/Sci/R&D Officer | 71 | 01/04/2002 | |
Carla Fiankan
LAW | General Counsel | - | 01/08/2011 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.08% | -0.99% | -1.34% | +11.57% | 46.86B | ||
| -0.61% | +4.26% | +396.16% | +647.20% | 40.23B | ||
| 0.00% | +4.93% | +11.81% | +55.56% | 36.23B | ||
| +2.48% | +4.57% | +7.05% | -5.05% | 34.72B | ||
| +0.62% | +3.53% | +5.41% | +42.19% | 27.89B | ||
| -2.00% | +11.64% | +31.71% | +136.81% | 16.79B | ||
| -0.17% | +0.66% | - | - | 16.74B | ||
| +0.78% | -5.88% | -2.68% | +7.76% | 13.12B | ||
| +1.82% | +1.56% | -9.75% | -30.15% | 12.7B | ||
| Average | +0.56% | +2.02% | +54.80% | +108.24% | 27.25B | |
| Weighted average by Cap. | +0.71% | +1.89% | +74.70% | +138.31% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
















